Application of synthetic biology in bladder cancer.
10.1097/CM9.0000000000002344
- Author:
Mengting DING
1
;
Jiaxing LIN
1
;
Caipeng QIN
1
;
Ping WEI
2
;
Jiahe TIAN
3
;
Tianxin LIN
4
;
Tao XU
1
Author Information
1. Department of Urology, Peking University People's Hospital, Beijing 100044, China.
2. Center for Cell and Gene Circuit Design, CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong 518055, China.
3. Department of Biological Sciences, University of Southern California, Los Angeles, CA 90089, USA.
4. Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong 528403, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Synthetic Biology;
Urinary Bladder Neoplasms/diagnosis*
- From:
Chinese Medical Journal
2022;135(18):2178-2187
- CountryChina
- Language:English
-
Abstract:
Bladder cancer (BC) is the most common malignant tumor of the genitourinary system. The age of individuals diagnosed with BC tends to decrease in recent years. A variety of standard therapeutic options are available for the clinical management of BC, but limitations exist. It is difficult to surgically eliminate small lesions, while radiation and chemotherapy damage normal tissues, leading to severe side effects. Therefore, new approaches are required to improve the efficacy and specificity of BC treatment. Synthetic biology is a field emerging in the last decade that refers to biological elements, devices, and materials that are artificially synthesized according to users' needs. In this review, we discuss how to utilize genetic elements to regulate BC-related gene expression periodically and quantitatively to inhibit the initiation and progression of BC. In addition, the design and construction of gene circuits to distinguish cancer cells from normal cells to kill the former but spare the latter are elaborated. Then, we introduce the development of genetically modified T cells for targeted attacks on BC. Finally, synthetic nanomaterials specializing in detecting and killing BC cells are detailed. This review aims to describe the innovative details of the clinical diagnosis and treatment of BC from the perspective of synthetic biology.
